Literature DB >> 16005243

The interleukin-6 -174 promoter polymorphism is associated with extrapulmonary bacterial dissemination in Streptococcus pneumoniae infection.

Bernhard Schaaf1, Jan Rupp, Michael Müller-Steinhardt, Jan Kruse, Florian Boehmke, Matthias Maass, Peter Zabel, Klaus Dalhoff.   

Abstract

Interleukin-6 (IL-6) is required for the clearance of bacteria in pneumococcal pneumonia. The abundance of endogenous IL-6 production on infectious stimuli is associated with genotypic differences in the -174 promoter region of IL-6 (-174 G-->C), showing increased IL-6 levels in patients carrying the GG genotype. One hundred patients with culturally proven pneumococcal disease were analyzed for distribution of the G-/C-alleles in the IL-6 -174 promoter region in comparison to 50 age-matched controls. Extrapulmonary pneumococcal dissemination, including septic metastasis, endocardial and meningeal infection, was used as parameter for impaired clearance of the bacteria. No significant differences in the allele distribution were observed between patients and controls. Within the patient group, the interleukin-6 GG homozygous carriers were less likely to develop extrapulmonary pneumococcal infection (10.3% versus 30.9%; OR 0.26, 95% CI 0.07-0.94, p=0.04). The IL-6 GG genotype, encoding for enhanced IL-6 secretion on bacterial stimuli, reduces the risk of bacterial spread to extrapulmonary sites in pneumococcal infection, possibly due to a more effective clearance of the pathogen from the blood and the respiratory tract.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16005243     DOI: 10.1016/j.cyto.2005.05.008

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  12 in total

Review 1.  Acute lower respiratory tract infection.

Authors:  Joseph P Mizgerd
Journal:  N Engl J Med       Date:  2008-02-14       Impact factor: 91.245

2.  Variants at the promoter of the interleukin-6 gene are associated with severity and outcome of pneumococcal community-acquired pneumonia.

Authors:  Ignacio Martín-Loeches; Jordi Solé-Violán; Felipe Rodríguez de Castro; M Isabel García-Laorden; Luis Borderías; José Blanquer; Olga Rajas; M Luisa Briones; Javier Aspa; Estefanía Herrera-Ramos; José Alberto Marcos-Ramos; Ithaisa Sologuren; Nereida González-Quevedo; José María Ferrer-Agüero; Judith Noda; Carlos Rodríguez-Gallego
Journal:  Intensive Care Med       Date:  2011-11-24       Impact factor: 17.440

3.  Clinical associations of host genetic variations in the genes of cytokines in critically ill patients.

Authors:  O B Belopolskaya; T V Smelaya; V V Moroz; A M Golubev; L E Salnikova
Journal:  Clin Exp Immunol       Date:  2015-04-03       Impact factor: 4.330

4.  CYP1A1, GCLC, AGT, AGTR1 gene-gene interactions in community-acquired pneumonia pulmonary complications.

Authors:  Lyubov E Salnikova; Tamara V Smelaya; Arkadiy M Golubev; Alexander V Rubanovich; Viktor V Moroz
Journal:  Mol Biol Rep       Date:  2013-09-26       Impact factor: 2.316

5.  Critical involvement of pneumolysin in production of interleukin-1alpha and caspase-1-dependent cytokines in infection with Streptococcus pneumoniae in vitro: a novel function of pneumolysin in caspase-1 activation.

Authors:  Shereen Shoma; Kohsuke Tsuchiya; Ikuo Kawamura; Takamasa Nomura; Hideki Hara; Ryosuke Uchiyama; Sylvia Daim; Masao Mitsuyama
Journal:  Infect Immun       Date:  2008-01-14       Impact factor: 3.441

6.  Associations of three well-characterized polymorphisms in the IL-6 and IL-10 genes with pneumonia: a meta-analysis.

Authors:  Hong Chen; Ning Li; Huanying Wan; Qijian Cheng; Guochao Shi; Yun Feng
Journal:  Sci Rep       Date:  2015-02-24       Impact factor: 4.379

7.  Genetic dissection of host immune response in pneumonia development and progression.

Authors:  Tamara V Smelaya; Olesya B Belopolskaya; Svetlana V Smirnova; Artem N Kuzovlev; Viktor V Moroz; Arkadiy M Golubev; Noel A Pabalan; Lyubov E Salnikova
Journal:  Sci Rep       Date:  2016-10-11       Impact factor: 4.379

8.  Successful downstream application of the Paxgene Blood RNA system from small blood samples in paediatric patients for quantitative PCR analysis.

Authors:  Enitan D Carrol; Fiona Salway; Stuart D Pepper; Emma Saunders; Limangeni A Mankhambo; William E Ollier; C Anthony Hart; Phillip Day
Journal:  BMC Immunol       Date:  2007-09-12       Impact factor: 3.615

9.  Contribution of IL6 -174 G>C and IL1B +3954 C>T polymorphisms to congenital infection with Toxoplasma gondii.

Authors:  W Wujcicka; Z Gaj; J Wilczyński; D Nowakowska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-18       Impact factor: 3.267

10.  Variation of 46 Innate Immune Genes Evaluated for their Contribution in Pneumococcal Meningitis Susceptibility and Outcome.

Authors:  Bart Ferwerda; Mercedes Valls Serón; Aldo Jongejan; Aeilko H Zwinderman; Madelijn Geldhoff; Arie van der Ende; Frank Baas; Matthijs C Brouwer; Diederik van de Beek
Journal:  EBioMedicine       Date:  2016-07-12       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.